Alpha-fetoprotein (AFP) has been the most widely used serum biomarker for HCC diagnosis, but the elevated serum AFP levels (>7 ng/ml) are also frequently observed in some patients with benign liver diseases (BLD), such as liver cirrhosis (LC) and chronic hepatitis (CH) [3]. This evidence concerns the gene AFP and chronic hepatitis.